Issued Patents All Time
Showing 25 most recent of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11679160 | Castration resistant prostate cancer | Esteban POMBO-VILLAR, Alexander Levitzki, Yael Langut, Maya Zigler, Alexei Shir | 2023-06-20 |
| 10947272 | BACE1 inhibitor peptides | Jeremy Beauchamp, Per-Ola Freskgard, Victor Lyamichev, Jigar Patel | 2021-03-16 |
| 10683329 | Dual-site BACE1 inhibitors | Per-Ola Freskgard | 2020-06-16 |
| 10428108 | Difluoroketamide derivatives | Benoit Hornsperger, Roberto Iacone, Hans-Peter Maerki, Michael Reutlinger, Peter Mohr | 2019-10-01 |
| 10208087 | Peptides | Per-Ola Freskgard | 2019-02-19 |
| 10137170 | Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptides | Sara Belli, Konrad Bleicher, Richard D. DiMarchi, Eike Hoffmann, Anish Ashok Konkar | 2018-11-27 |
| 9968647 | Small molecule conjugates for intracellular delivery of biologically active compounds | Philipp Hadwiger, Torsten Hoffmann, Kerstin Jahn-Hofmann, David L. Lewis, Peter Mohr +4 more | 2018-05-15 |
| 9868772 | Analogs of glucagon exhibiting GIP receptor activity | Richard D. DiMarchi, David L. Smiley, Konrad Bleicher | 2018-01-16 |
| 9796756 | Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA | Philipp Hadwiger, Torsten Hoffmann, Peter Mohr, Ingo Roehl, Linda Valis +3 more | 2017-10-24 |
| 9301990 | Small molecule conjugates for intracellular delivery of biologically active compounds | Philipp Hadwiger, Torsten Hoffmann, Kerstin Jahn-Hofmann, David L. Lewis, Peter Mohr +4 more | 2016-04-05 |
| 9249179 | Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA | Philipp Hadwiger, Torsten Hoffmann, Peter Mohr, Ingo Roehl, Linda Valis +3 more | 2016-02-02 |
| 9198947 | Small molecule conjugates for intracellular delivery of nucleic acids | Philipp Hadwiger, Torsten Hoffmann, Kerstin Jahn-Hofmann, David L. Lewis, Peter Mohr +4 more | 2015-12-01 |
| 9107957 | Peptide-based in vivo siRNA delivery system | David B. Rozema, David L. Lewis, Darren H. Wakefield, Philipp Hadwiger, Jon Wolff +9 more | 2015-08-18 |
| 9011919 | Compositions for targeted delivery of siRNA | David B. Rozema, David L. Lewis, Darren H. Wakefield, Torsten Hoffmann, Peter Mohr +3 more | 2015-04-21 |
| 8802773 | In vivo polynucleotide delivery conjugates having enzyme sensitive linkages | David B. Rozema, David L. Lewis, Darren H. Wakefield, Philipp Hadwiger, Jon Wolff +9 more | 2014-08-12 |
| 8501930 | Peptide-based in vivo siRNA delivery system | David B. Rozema, Darren H. Wakefield, David L. Lewis, Jon Wolff, Andrei V. Blokhin +9 more | 2013-08-06 |
| 8426554 | In vivo polynucleotide delivery conjugates having enzyme sensitive linkages | David B. Rozema, Darren H. Wakefield, David L. Lewis, Jon Wolff, Andrei V. Blokhin +9 more | 2013-04-23 |
| 8163778 | Pyridines as FBPase inhibitors for treatment of diabetes | Wolfgang Haap, Paul Hebeisen, Bernd Kuhn, Peter Mohr, Hans Peter Wessel | 2012-04-24 |
| 7973051 | Aminothiazoles as FBPase inhibitors for diabetes | Paul Hebeisen, Rudolf E. Minder, Peter Mohr, Hans Peter Wessel | 2011-07-05 |
| 7964633 | Sulfonamide derivatives | Wolfgang Haap, Paul Hebeisen, Philipp KOHLER, Holger Kuehne, Armin Ruf | 2011-06-21 |
| 7868030 | FBPase inhibitors for diabetes | Marcel Gubler, Wolfgang Haap, Paul Hebeisen, Bernd Kuhn, Rudolf E. Minder +2 more | 2011-01-11 |
| 7501406 | Fluoro substituted 2-oxo-azepan derivatives | Alexander Flohr, Guido Galley, Roland Jakob-Roetne, Wolfgang Wostl | 2009-03-10 |
| 7375099 | Malonamide derivatives | Guido Galley, Annick Goergler, Helmut Jacobsen, Jens-Uwe Peters | 2008-05-20 |
| 7253158 | Sulfonamides | Guido Galley, Roland Jakob-Roetne | 2007-08-07 |
| 7189756 | Pyrrolidine derivatives | Johannes Aebi, Daniel Bur, Alexander Chucholowski, Henrietta Dehmlow, Ulrike Obst +1 more | 2007-03-13 |